> Sepracor's layoffs weren't the only news to come out of its earnings announcement yesterday; the company also will expand its Boston-area offices with a 150,000-square-foot building next to HQ. Report
> Sanofi-Aventis reported a 9.1 percent spike in profits on strong sales of vaccines and its anti-clotting drug Plavix. Report
> Novo Nordisk reported a leap in third-quarter profits to $421 million, but lowered its full-year sales expectations because of currency exchange rates. Report
> Nycomed is buying Bradley Pharmaceuticals for $346 million cash, or $20 a share. Report
> India's Glenmark Pharmaceuticals posted profits of $18.4 million on revenues of $93.8 million for the quarter--growth of 50 percent and 88 percent respectively. Report
> Scientists at Brookhaven National Laboratory have added to the store of knowledge linking dopamine to obesity. Report
> Sangamo shares leap on stem cell tech advance. Report
> Researchers at the University of Cincinnati have identified a new target for drug developers out to control obesity and diabetes. Report
And Finally… Here's one reason to wear pajamas when you're on the road--or develop a new sleeping pill back home: an epidemic of sleepwalking through hotel lobbies. Report